ストックスクリーナーアプリを入手
0.585
21.12%
0.102
前日終値:
$0.483
開ける：
$0.5
24時間の取引高:
12.07M
Relative Volume:
0.45
時価総額：
$35.39M
収益：
-
当期純損益:
$-12.89M
株価収益率:
-0.2312
EPS:
-2.53
ネットキャッシュフロー:
$-11.95M
1週間 パフォーマンス:
+10.42%
1か月 パフォーマンス:
+88.65%
6か月 パフォーマンス:
-52.82%
1年 パフォーマンス:
-67.50%
1日の値動き範囲:
$0.4906
$0.585
1週間の範囲:
$0.45
$0.6114
52週間の値動き範囲:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
PSTV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.585 | 29.22M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-17 | 開始されました | D. Boral Capital | Buy |
| 2021-01-25 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-10-16 | 開始されました | Maxim Group | Buy |
Plus Therapeutics Inc (PSTV) 最新ニュース
How strong is Plus Therapeutics Inc. company’s balance sheetEarnings Report Planner For 2025 - jammulinksnews.com
Published on: 2025-08-01 22:18:13 - metal.it
Plus Therapeutics (PSTV.O) Surges 16.5% — What's Behind the Sharp Move? - AInvest
What are analysts’ price targets for Plus Therapeutics Inc. in the next 12 monthsStock Strategy Recommendation From AI Tools - jammulinksnews.com
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic - GlobeNewswire
What is the risk reward ratio of investing in Plus Therapeutics Inc. stockSmart Portfolio Recommendation For Beginners - jammulinksnews.com
Plus Therapeutics (PSTV) to Introduce CNSide Diagnostics in Texas by August 2025 - GuruFocus
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic | PSTV Stock News - GuruFocus
Revolutionary CNS Cancer Test With 92% Accuracy Launches at Major Texas Cancer Centers - Stock Titan
Is Plus Therapeutics Inc. stock overvalued or undervaluedReal Time Watchlist With Proven Results - jammulinksnews.com
What makes Plus Therapeutics Inc. stock price move sharplyReliable Alerts for Daily Stock Movers Released - metal.it
Plus Therapeutics (PSTV.O) Plunges 13%: Unpacking the Intraday Shock - AInvest
Institutional Tools Highlight Unusual Flow in Plus Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it
What is the dividend policy of Plus Therapeutics Inc. stockGet daily expert analysis for smarter investing - jammulinksnews.com
Does Plus Therapeutics Inc. stock perform well during market downturnsBuild wealth steadily with proven investment techniques - jammulinksnews.com
Why is Plus Therapeutics Inc. stock attracting strong analyst attentionAmplify your gains with low-risk picks - jammulinksnews.com
How does Plus Therapeutics Inc. generate profit in a changing economyBoost your wealth with consistent growth stocks - jammulinksnews.com
What catalysts could drive Plus Therapeutics Inc. stock higher in 2025Unlock rapid growth potential in your portfolio - jammulinksnews.com
How volatile is Plus Therapeutics Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
Published on: 2025-07-27 20:49:15 - jammulinksnews.com
Healthcare Stocks Move in Intrday Session: Gainers and Losers - AInvest
What drives Plus Therapeutics Inc. stock priceOutstanding capital appreciation - PrintWeekIndia
What analysts say about Plus Therapeutics Inc. stockFree Stock Chart Pattern Guide - Autocar Professional
Should I buy Plus Therapeutics Inc. stock before earningsRecord-setting profit potential - jammulinksnews.com
Can Plus Therapeutics Inc. stock recover from recent declineFree Consultation - jammulinksnews.com
Plus Therapeutics Skyrockets 22.22%—What’s Fueling This Volatility? - AInvest
Plus Therapeutics Soars 32.65% on $1.6M CPRIT Payment - AInvest
Why Did Plus Therapeutics (PSTV) Soar 12.24%? - AInvest
Plus Therapeutics Soars 12.65% on $17.6M CPRIT Grant for Cancer Research - AInvest
Plus Therapeutics shares rise 12.86% premarket after receiving $1.6 million advance payment from CPRIT. - AInvest
Is Plus Therapeutics Inc. a good long term investmentPhenomenal returns - Autocar Professional
Plus Therapeutics (PSTV) Secures $1.6 Million Advance from Texas Institute - GuruFocus
Plus Therapeutics Soared 22.18%—What’s Next for This Biotech Breakout? - AInvest
Plus Therapeutics (PSTV) Receives $1.6M Advance from CPRIT Grant | PSTV Stock News - GuruFocus
Plus Therapeutics: Leveraging Non-Dilutive Funding to Accelerate CNS Cancer Innovation - AInvest
Plus Therapeutics Inc. Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com
Plus Therapeutics Announces $1.6 Million Advance Payment from CP - GuruFocus
Plus Therapeutics (PSTV) Receives $1.6M Advance from CPRIT Grant - GuruFocus
Plus Therapeutics, Inc. Secures $1.6 Million Advance Payment from CPRIT to Support CNS Cancer Research and Development - Nasdaq
Plus Therapeutics receives $1.6 million advance from CPRIT grant - Investing.com
Plus Therapeutics receives $1.6 million advance from CPRIT grant By Investing.com - Investing.com UK
Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT - GlobeNewswire
Plus Therapeutics Inc (PSTV) 財務データ
収益
当期純利益
現金流量
EPS
Plus Therapeutics Inc (PSTV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hawkins Richard J | Director |
Sep 13 '24 |
Buy |
1.50 |
4,000 |
5,996 |
15,188 |
| Hawkins Richard J | Director |
Sep 12 '24 |
Buy |
1.35 |
6,285 |
8,512 |
11,188 |
| Petersen Greg | Director |
Sep 11 '24 |
Buy |
1.35 |
12,500 |
16,875 |
48,921 |
| Clowes Howard | Director |
Sep 11 '24 |
Buy |
1.34 |
5,000 |
6,681 |
26,497 |
| HEDRICK MARC H | Chief Executive Officer |
Sep 10 '24 |
Buy |
1.23 |
8,000 |
9,839 |
20,425 |
| Sims Andrew John Hugh MacIntyr | Chief Financial Officer |
Sep 10 '24 |
Buy |
1.27 |
4,098 |
5,204 |
9,815 |
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):